Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.
By C. Rohlfing, H. Wiedmeyer, R. Little, J. England, Alethea L Tennill, D. Goldstein. Diabetes Care, 2002
1,124 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/3267ee0198ebcc1af0cd71c06e493999d1b7a907
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives. (2005, methodology): “As HbA1c is an integrated measure of glucose exposure over daytime [9] and since both interprandial [10] and postprandial glucose concentrations [11, 12] are highly correlated with HbA1c, the current position statements on glycaemic control have been revised in order to provide the correlation betwe”
- Standards of Medical Care in Diabetes—2008 (2008, methodology): “These estimates are based on DCCT data (34).”
- Phenolic Compounds in Honey and Their Associated Health Benefits: A Review (2018, background): “The measurement of fructosamine, glycosylated hemoglobin, and glucose is common and fundamental in the practice of glycemic control in patients with diabetes mellitus [89].”
- Standards of Medical Care in Diabetes—2012 (2011, methodology): “Table 7 contains the correlation between A1C levels and mean plasma glucose levels based on data from the DCCT (30).”
- Standards of Medical Care in Diabetes—2013 (2012, methodology): “Follow-up of the DCCT cohorts in the Epidemiology of Diabetes Interventions and Complications (EDIC) study (80,81) demonstrated persistence of these microvascular benefits in previously intensively treated subjects, even though their glycemic control approximated that of previous standard arm subjec”
- Standards of Medical Care in Diabetes–2006 (2006, methodology): “Prospective randomized clinical trials such as the DCCT (25) and the U.K. Prospective Diabetes Study (UKPDS) (26,27) have shown that improved glycemic control is associated with sustained decreased rates of retinopathy, nephropathy, and neuropathy (28).”
- Standards of Medical Care in Diabetes—2014 (2013, methodology): “In the 9-year post-DCCT follow-up of the EDIC cohort, participants previously randomized to the intensive arm had a significant 57% reduction in the risk of nonfatal myocardial infarction (MI), stroke, or CVD death comparedwith those previously in the standard arm (92).”